• Something wrong with this record ?

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents

L. Hauer, J. Jambura, D. Hrusak, M. Chalupova, P. Posta, S. Rusnak, V. Vyskocil

. 2020 ; 164 (1) : 100-107. [pub] 20190110

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21006949

BACKGROUND: Medication - related osteonecrosis of the jaw (MRONJ) is a rare but serious complication of antiresorptive and/or antiangiogenic therapy. It mainly affects oncological patients, however, it can occur in patients with metabolic bone diseases, although this is less frequent. These lesions not only significantly impair the quality of life but can also have impact on the treatment of any underlying disease. In some rare cases MRONJ can be life-threatening. There is still no ideal consensus for treatment, though surgical therapy has been mostly preferred in recent years. MATERIALS AND METHODS: A monocentric retrospective evaluation of surgical therapy of MRONJ in osteoporotic patients, treated in the time period 3/2014-3/2018 using the uniform department-specific protocol. RESULTS: 26 osteoporotic patients with 32 MRONJ lesions of stage 1 (9%), stage 2 (75%) and stage 3 (16%) were treated surgically. The maxilla: mandibula ratio was 1:2.2, in 19% of patients there was multiple jaw involvement. 69.2% of patients had received bisphosphonates, 15.4% denosumab and 15.4% had a history of both types of antiresorptive treatment. Complete healing was observed in all patients, in 9% of cases by secondary intention in the mean period of 6 weeks. The mean follow-up was 20.5 months. CONCLUSION: The presented protocol for surgical therapy was effective in the management of all MRONJ stages in the osteoporotic patients described here. The surgery is indicated as an early treatment to prevent complications and the progression of the lesions. It leads to improvement in quality of life and option to resume antiresorptive therapy if interrupted.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21006949
003      
CZ-PrNML
005      
20210503123841.0
007      
ta
008      
210309s2020 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.081 $2 doi
035    __
$a (PubMed)30647474
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hauer, Lukáš, $d 1980- $7 xx0138820 $u Department of Oral and Maxillofacial Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
245    10
$a Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents / $c L. Hauer, J. Jambura, D. Hrusak, M. Chalupova, P. Posta, S. Rusnak, V. Vyskocil
504    __
$a Literatura
520    9_
$a BACKGROUND: Medication - related osteonecrosis of the jaw (MRONJ) is a rare but serious complication of antiresorptive and/or antiangiogenic therapy. It mainly affects oncological patients, however, it can occur in patients with metabolic bone diseases, although this is less frequent. These lesions not only significantly impair the quality of life but can also have impact on the treatment of any underlying disease. In some rare cases MRONJ can be life-threatening. There is still no ideal consensus for treatment, though surgical therapy has been mostly preferred in recent years. MATERIALS AND METHODS: A monocentric retrospective evaluation of surgical therapy of MRONJ in osteoporotic patients, treated in the time period 3/2014-3/2018 using the uniform department-specific protocol. RESULTS: 26 osteoporotic patients with 32 MRONJ lesions of stage 1 (9%), stage 2 (75%) and stage 3 (16%) were treated surgically. The maxilla: mandibula ratio was 1:2.2, in 19% of patients there was multiple jaw involvement. 69.2% of patients had received bisphosphonates, 15.4% denosumab and 15.4% had a history of both types of antiresorptive treatment. Complete healing was observed in all patients, in 9% of cases by secondary intention in the mean period of 6 weeks. The mean follow-up was 20.5 months. CONCLUSION: The presented protocol for surgical therapy was effective in the management of all MRONJ stages in the osteoporotic patients described here. The surgery is indicated as an early treatment to prevent complications and the progression of the lesions. It leads to improvement in quality of life and option to resume antiresorptive therapy if interrupted.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a bisfosfonátová osteonekróza čelistí $x diagnóza $x etiologie $x chirurgie $7 D059266
650    _2
$a inhibitory kostní resorpce $x škodlivé účinky $7 D050071
650    _2
$a bisfosfonáty $x škodlivé účinky $7 D004164
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a ortognátní chirurgické výkony $7 D056948
650    _2
$a osteoporóza $x farmakoterapie $7 D010024
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jambura, Jan, $d 1983- $7 xx0138835 $u Department of Oral and Maxillofacial Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
700    1_
$a Hrušák, Daniel $7 xx0105271 $u Department of Oral and Maxillofacial Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
700    1_
$a Chalupová, Miroslava, $d 1991- $7 xx0244067 $u Department of Oral and Maxillofacial Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
700    1_
$a Pošta, Petr, $d 1983- $7 xx0228381 $u Department of Oral and Maxillofacial Surgery, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 80, 304 60 Pilsen, Czech Republic
700    1_
$a Rusňák, Štěpán $7 xx0106252 $u Clinic of Ophthalmology, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
700    1_
$a Vyskočil, Václav $7 hka2010562188 $u Osteocentre of the 2 nd Internal Medicine Clinic, University Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 1 (2020), s. 100-107
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30647474 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20210309 $b ABA008
991    __
$a 20210408121000 $b ABA008
999    __
$a ok $b bmc $g 1648171 $s 1127287
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c 1 $d 100-107 $e 20190110 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20210309

Find record

Citation metrics

Archiving options